World PulseNow
Newsletter

Alnylam pulls heart drug TV ad amid FDA crackdown

Investing.com•Thursday, October 2, 2025 at 2:52:33 PM
NegativeFinancial Markets
Alnylam pulls heart drug TV ad amid FDA crackdown
Alnylam Pharmaceuticals has decided to pull its television advertisement for a heart drug following increased scrutiny from the FDA. This move highlights the ongoing tension between pharmaceutical companies and regulatory bodies, especially as the FDA intensifies its efforts to ensure that drug marketing is both truthful and not misleading. The decision may impact Alnylam's visibility and sales, raising questions about the future of direct-to-consumer advertising in the pharmaceutical industry.
— Curated by the World Pulse Now AI Editorial System
Read Original

Was this article worth reading? Share it

Recommended Readings
Taysha Gene Therapies stock soars after FDA breakthrough therapy designation
Investing.com8 hours ago
Taysha Gene Therapies stock soars after FDA breakthrough therapy designation
PositiveFinancial Markets
Taysha Gene Therapies has received a breakthrough therapy designation from the FDA, causing its stock to soar. This designation is significant as it can expedite the development and review process for new treatments, highlighting the company's potential in the gene therapy sector. Investors are optimistic about the future of Taysha, as this recognition could lead to faster access to innovative therapies for patients.
Read full article
via Investing.com
SS Innovations completes key study for surgical robot FDA submission
Investing.com8 hours ago
SS Innovations completes key study for surgical robot FDA submission
PositiveFinancial Markets
SS Innovations has successfully completed a crucial study that paves the way for their surgical robot's submission to the FDA. This milestone is significant as it brings the company closer to introducing innovative robotic solutions in surgery, which could enhance precision and patient outcomes. The advancement in surgical technology is not only a win for SS Innovations but also a promising development for the healthcare industry, potentially transforming surgical procedures.
Read full article
via Investing.com
Fortress Biotech stock faces setback as FDA issues CRL for CUTX-101
Investing.com9 hours ago
Fortress Biotech stock faces setback as FDA issues CRL for CUTX-101
NegativeFinancial Markets
Fortress Biotech's stock has taken a hit following the FDA's issuance of a Complete Response Letter (CRL) for its drug CUTX-101. This setback is significant as it delays the potential approval of a treatment that many hoped would address unmet medical needs. Investors are understandably concerned about the implications for the company's future and its ability to bring innovative therapies to market.
Read full article
via Investing.com
Vanda and FDA agree on framework to resolve drug disputes
Investing.coma day ago
Vanda and FDA agree on framework to resolve drug disputes
PositiveFinancial Markets
Vanda Pharmaceuticals and the FDA have reached a significant agreement on a framework to resolve disputes related to drug approvals. This collaboration is crucial as it aims to streamline the approval process, ensuring that patients have timely access to necessary medications. By establishing clear guidelines, both parties hope to reduce conflicts and enhance the overall efficiency of drug development, ultimately benefiting public health.
Read full article
via Investing.com
Novartis gets FDA approval for oral CSU treatment Rhapsido
Investing.com2 days ago
Novartis gets FDA approval for oral CSU treatment Rhapsido
PositiveFinancial Markets
Novartis has received FDA approval for Rhapsido, an oral treatment for chronic spontaneous urticaria (CSU). This is significant as it offers a new option for patients suffering from this condition, which can severely impact quality of life. With Rhapsido now available, patients may experience relief from symptoms more effectively, marking a positive advancement in the treatment landscape.
Read full article
via Investing.com
Novartis receives FDA approval for oral CSU treatment Rhapsido
Investing.com2 days ago
Novartis receives FDA approval for oral CSU treatment Rhapsido
PositiveFinancial Markets
Novartis has received FDA approval for its oral treatment Rhapsido for chronic spontaneous urticaria (CSU), marking a significant advancement in allergy management. This approval is crucial as it provides patients with a new option to manage their symptoms effectively, potentially improving their quality of life. The introduction of Rhapsido could change the landscape of CSU treatment, offering hope to those who struggle with this condition.
Read full article
via Investing.com
Zoetis stock rises after FDA conditionally approves screwworm drug
Investing.com2 days ago
Zoetis stock rises after FDA conditionally approves screwworm drug
PositiveFinancial Markets
Zoetis has seen a significant rise in its stock value following the FDA's conditional approval of its new screwworm drug. This approval is a major milestone for the company, as it opens up new avenues for addressing a critical agricultural pest that affects livestock. The positive market reaction reflects investor confidence in Zoetis's innovative approach to animal health, which could lead to increased sales and a stronger position in the pharmaceutical industry.
Read full article
via Investing.com
IO Biotech stock rating downgraded to Hold by TD Cowen on FDA setback
Investing.com3 days ago
IO Biotech stock rating downgraded to Hold by TD Cowen on FDA setback
NegativeFinancial Markets
IO Biotech's stock rating has been downgraded to 'Hold' by TD Cowen following a setback with the FDA. This news is significant as it reflects concerns about the company's future prospects and regulatory challenges, which could impact investor confidence and stock performance.
Read full article
via Investing.com
Latest from Financial Markets
What are your financial goals? We want to hear about them.
The New York Timesan hour ago
What are your financial goals? We want to hear about them.
PositiveFinancial Markets
Setting financial goals is an important journey that can be filled with both challenges and triumphs. As you work towards achieving these milestones, sharing your experiences can inspire others and create a supportive community. We want to hear about your financial aspirations and the steps you're taking to reach them, as this dialogue can help everyone navigate their own financial paths.
Read full article
via The New York Times
Trump Calls Shutdown an ‘Unprecedented Opportunity,’ and Eyes Deep Cuts
The New York Timesan hour ago
Trump Calls Shutdown an ‘Unprecedented Opportunity,’ and Eyes Deep Cuts
PositiveFinancial Markets
Former President Donald Trump has described the potential government shutdown as an 'unprecedented opportunity' to implement significant budget cuts. This perspective highlights his ongoing influence in shaping fiscal policies and suggests that he sees this moment as a chance to push for deeper reductions in government spending. Such cuts could have far-reaching implications for various programs and services, making it a critical issue for lawmakers and citizens alike.
Read full article
via The New York Times
JBS returns to Paraguay with $70 million investment, including plant purchase
Investing.coman hour ago
JBS returns to Paraguay with $70 million investment, including plant purchase
PositiveFinancial Markets
JBS is making a significant comeback in Paraguay with a $70 million investment that includes the purchase of a local plant. This move not only strengthens JBS's presence in the region but also promises to boost the local economy by creating jobs and enhancing agricultural production. It's a win-win situation that highlights the importance of foreign investment in fostering growth and development in Paraguay.
Read full article
via Investing.com
Google reaches agreement with NBCUniversal to prevent YouTube content blackout
Investing.coman hour ago
Google reaches agreement with NBCUniversal to prevent YouTube content blackout
PositiveFinancial Markets
Google has successfully reached an agreement with NBCUniversal, ensuring that YouTube content will remain accessible to viewers. This deal is significant as it prevents a potential blackout that could have affected millions of users who rely on the platform for entertainment and news. By resolving this issue, both companies demonstrate their commitment to providing uninterrupted access to quality content, which is crucial in today's digital landscape.
Read full article
via Investing.com
Philadelphia Agency Eyes US Loan to Replace Trains After Fires
Bloombergan hour ago
Philadelphia Agency Eyes US Loan to Replace Trains After Fires
PositiveFinancial Markets
Philadelphia's transit system is considering applying for a loan from the US government to purchase new commuter trains following a series of fires this year. This move is significant as it aims to enhance safety and reliability for commuters, ensuring that the transit system can continue to serve the community effectively.
Read full article
via Bloomberg
The NFL is launching professional flag football leagues for both men and women, Commissioner Roger Goodell says
Fortunean hour ago
The NFL is launching professional flag football leagues for both men and women, Commissioner Roger Goodell says
PositiveFinancial Markets
The NFL is taking a significant step by launching professional flag football leagues for both men and women, as announced by Commissioner Roger Goodell in London. This initiative not only promotes inclusivity in sports but also provides new opportunities for athletes to showcase their skills in a growing format. The commitment to a women's professional league is particularly noteworthy, as it reflects the NFL's dedication to expanding the reach of football beyond traditional boundaries.
Read full article
via Fortune